↓ Skip to main content

Corticosteroids for preventing relapse following acute exacerbations of asthma

Overview of attention for article published in Cochrane database of systematic reviews, July 2007
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

blogs
1 blog
wikipedia
1 Wikipedia page

Citations

dimensions_citation
130 Dimensions

Readers on

mendeley
166 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Corticosteroids for preventing relapse following acute exacerbations of asthma
Published in
Cochrane database of systematic reviews, July 2007
DOI 10.1002/14651858.cd000195.pub2
Pubmed ID
Authors

Brian H Rowe, Carol Spooner, Francine Ducharme, Jennifer Bretzlaff, Gary Bota

Abstract

Acute asthma is responsible for many emergency department (ED) visits annually. Between 12 to 16% will relapse to require additional interventions within two weeks of ED discharge. Treatment of acute asthma is based on rapid reversal of bronchospasm and reducing airway inflammation.

Mendeley readers

The data shown below were compiled from readership statistics for 166 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 1%
Japan 1 <1%
Korea, Republic of 1 <1%
Denmark 1 <1%
Unknown 161 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 28 17%
Researcher 25 15%
Student > Bachelor 19 11%
Student > Postgraduate 18 11%
Student > Ph. D. Student 16 10%
Other 44 27%
Unknown 16 10%
Readers by discipline Count As %
Medicine and Dentistry 109 66%
Agricultural and Biological Sciences 9 5%
Nursing and Health Professions 8 5%
Social Sciences 5 3%
Pharmacology, Toxicology and Pharmaceutical Science 4 2%
Other 8 5%
Unknown 23 14%

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 October 2019.
All research outputs
#2,554,830
of 16,024,112 outputs
Outputs from Cochrane database of systematic reviews
#5,244
of 11,361 outputs
Outputs of similar age
#30,863
of 189,168 outputs
Outputs of similar age from Cochrane database of systematic reviews
#47
of 102 outputs
Altmetric has tracked 16,024,112 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,361 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 23.7. This one has gotten more attention than average, scoring higher than 53% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 189,168 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 102 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.